NASDAQ : NRC
National Research Corporation — Key statistics
Healthcare · Health Information Services · United States
Last price 23.49 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 498.49M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 505.71M |
| Enterprise Value | 604.98M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Dec 29, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 21.22M |
| Shares Outstanding | 21.22M |
| Shares Change (YoY) | -3.58% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 48.55% |
| Owned by Institutions (%) | 53.57% |
| Float | 10.92M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 88.91 |
| Forward PE | 24.07 |
| PS Ratio | 3.52 |
| Forward PS | 3.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.41 |
| P/OCF Ratio | 21.28 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 98.64 |
| EV / Sales | 4.21 |
| EV / EBITDA | 19.39 |
| EV / EBIT | 26.66 |
| EV / FCF | 32.79 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.64 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.30 |
| Debt / FCF | 5.58 |
| Interest Coverage | 4.14 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 248.11% |
| Return on Assets (ROA) | 10.32% |
| Return on Invested Capital (ROIC) | 14.56% |
| Return on Capital Employed (ROCE) | 23.31% |
| Weighted Average Cost of Capital (WACC) | 5.19% |
| Revenue Per Employee | $402,768 |
| Profits Per Employee | $17,179 |
| Employee Count | 357 |
| Asset Turnover | 1.05 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.07M |
| Effective Tax Rate | 38.73% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +77.18% |
| 50-Day Moving Average | 21.22 |
| 200-Day Moving Average | 19.17 |
| Relative Strength Index (RSI) | 66.69 |
| Average Volume (20 Days) | 89,024 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 725,577 |
| Short Previous Month | 685,621 |
| Short % of Shares Out | 3.42% |
| Short % of Float | 6.65% |
| Short Ratio (days to cover) | 6.33 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 143.79M |
| Gross Profit | 87.27M |
| Operating Income | 22.70M |
| Pretax Income | 10.51M |
| Net Income | 6.13M |
| EBITDA | 31.20M |
| EBIT | 22.70M |
| Earnings Per Share (EPS) | $0.27 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.63M |
| Total Debt | 102.90M |
| Net Cash | -99.27M |
| Net Cash Per Share | -$4.68 |
| Equity (Book Value) | -9.12M |
| Book Value Per Share | -0.43 |
| Working Capital | -15.14M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 23.77M |
| Capital Expenditures | -5.32M |
| Depreciation & Amortization | 8.50M |
| Net Borrowing | 22.74M |
| Free Cash Flow | 18.45M |
| FCF Per Share | $0.87 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.69% |
| Operating Margin | 15.78% |
| Pretax Margin | 7.31% |
| Profit Margin | 4.48% |
| EBITDA Margin | 21.70% |
| EBIT Margin | 15.78% |
| FCF Margin | 12.83% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.64 |
| Dividend Yield | 2.69% |
| Dividend Growth (YoY) | 23.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 238.78% |
| FCF Payout Ratio | 73.62% |
| Buyback Yield | 3.58% |
| Shareholder Yield | 6.26% |
| Earnings Yield | 1.12% |
| FCF Yield | 3.65% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 6.29% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |